Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy in Limited-Stage Small Cell Lung Cancer

NCT06784206 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Cancer, Limited Stage
Hyperfractionated Accelerated Radiotherapy
Simultaneous Radiotherapy and Chemotherapy

Interventions

DRUG: Adebrelimab Maintenance Therapy After Concurrent Chemoradiotherapy with Hyperfractionated Radiotherapy

Sponsor

Peking University Cancer Hospital & Institute